glp 1 drug coverage What to Make of the GLP-1 and Cost Landscape Employers Grapple with Claims Costs

Cocaine Only limited clinical evidence is available for GLP-1RAs in cocaine misuse: a small ( N = 13) proof-of-concept trial across 2 days showed that exenatide compared with placebo did not reduce the number of self-administered cocaine infusions 115 , while a case series of 3 individuals with cocaine-use disorder highlighted the feasibility and safety of using the same drug over 6 weeks, although no efficacy measures were reported 116

He was previously a physician-scientist at Indiana University, where he practiced as an endocrinologist while conducting research focused on preventing heart disease and other diabetes complications

Lancet Diabetes Endocrinol 2018;6:60517

In addition, hyperinsulinemia is responsible for the increase in the androgen production through both the direct stimulation of insulin receptors and the cross-reaction with Insulin-like Growth Factor-1 (IGF-1) receptors expressed on thecal cells [14]

As millions of patients gain access to popular weight-loss medications, physicians and health systems face a growing landscape of liability risks they need to prepare for now

A.RainerQ.WangJ